Elutia Inc. financial data

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
AZIYO BIOLOGICS, INC. (to 8/14/2023)
Latest financial report
10-K - Q4 2024 - Mar 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 75.9 % -13%
Quick Ratio 8.83 % -50.5%
Debt-to-equity -180 % +41%
Return On Equity 107 % -27.1%
Return On Assets -133 % -86.8%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 105M USD +603%
Weighted Average Number of Shares Outstanding, Basic 29.1M shares +60.1%
Weighted Average Number of Shares Outstanding, Diluted 29.1M shares +60.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.79M USD -14%
Selling and Marketing Expense 12.5M USD -4.13%
General and Administrative Expense 18.7M USD +32.3%
Operating Income (Loss) -35.7M USD -16.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -54.1M USD -31.3%
Income Tax Expense (Benefit) 7K USD -75%
Net Income (Loss) Attributable to Parent -53.9M USD -43.3%
Earnings Per Share, Basic -1.86 USD/shares +10.1%
Earnings Per Share, Diluted -1.86 USD/shares +10.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.2M USD -31.3%
Accounts Receivable, after Allowance for Credit Loss, Current 2.28M USD -30.2%
Inventory, Net 3.91M USD +1.51%
Assets, Current 26.2M USD -16.3%
Property, Plant and Equipment, Net 773K USD +349%
Operating Lease, Right-of-Use Asset 860K USD +217%
Intangible Assets, Net (Excluding Goodwill) 8.27M USD -29.1%
Other Assets, Noncurrent 909K USD +174%
Assets 36.1M USD -16.8%
Accounts Payable, Current 4.15M USD +30%
Accrued Liabilities, Current 7.1M USD -25.1%
Liabilities, Current 37.8M USD -12.2%
Operating Lease, Liability, Noncurrent 423K USD
Other Liabilities, Noncurrent 1.56M USD +259%
Liabilities 82.4M USD +0.44%
Retained Earnings (Accumulated Deficit) -230M USD -30.7%
Stockholders' Equity Attributable to Parent -46.3M USD -19.8%
Liabilities and Equity 36.1M USD -16.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.64M USD +48.9%
Net Cash Provided by (Used in) Financing Activities -4.07M USD -2849%
Net Cash Provided by (Used in) Investing Activities -15K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.2M USD -31.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.54M USD +344%
Deferred Tax Assets, Valuation Allowance 47.4M USD +21.6%
Deferred Tax Assets, Gross 48M USD +21.5%
Operating Lease, Liability 883K USD +221%
Payments to Acquire Property, Plant, and Equipment 15K USD -91.8%
Lessee, Operating Lease, Liability, to be Paid 1M USD +256%
Property, Plant and Equipment, Gross 1.41M USD +86.9%
Operating Lease, Liability, Current 460K USD +67.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 454K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 546K USD +94.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +83.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 117K USD +1850%
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD
Deferred Tax Assets, Operating Loss Carryforwards 29.7M USD +27.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 183M USD +33.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.4M USD 0%
Depreciation, Depletion and Amortization 864K USD -8.77%
Share-based Payment Arrangement, Expense 7.89M USD +228%
Interest Expense 5.68M USD +6.49%